TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Details
01. General Information
Name Auranofin
PubChem CID 24199313
Molecular Weight 678.5g/mol
Synonyms

34031-32-8, AURANOFIN, (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate, AUJRCFUBUPVWSZ-UHFFFAOYSA-M, BCP08217, MMV688978, SKF 39162, AKOS026750078, FT-0662343, D78135, A937040, 1-Thio-|A-D-glucopyranosatotriethylphosphine gold-2,3,4,6-tetraacetate, 1-Thio-beta-D-glucopyranosatotriethyl phosphine gold-2,3,4,6-tetraacetate, 3,4,5-Triacetyloxy-6-(acetyloxymethyl) oxane-2-thiolate triethylphosphanium, gold(1+) [3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]sulfanide triethylphosphine, gold(1+);3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane, SKF-39162; SKF-D-39162; SKF 39162; SKF D 39162; SKFD-39162; SKFD39162

Drug Type Small molecule
Formula C₂₀H₃₄AuO₉PS
SMILES CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+]
InChI 1S/C14H20O9S.C6H15P.Au/c1-6(15)19-5-10-11(20-7(2)16)12(21-8(3)17)13(14(24)23-10)22-9(4)18;1-4-7(5-2)6-3;/h10-14,24H,5H2,1-4H3;4-6H2,1-3H3;/q;;+1/p-1
InChIKey AUJRCFUBUPVWSZ-UHFFFAOYSA-M
CAS Number 34031-32-8
TTD ID D0L2UN
Drug Bank ID DB00995
Toxicity Organism Test Type Route(Dose)
rat LD50 intraperitoneal(165 mg/kg)
mouse LD50 intraperitoneal(254 mg/kg)
rat LD50 oral(322 mg/kg)
Structure 2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 571
Pair Name Vitamin K3, Auranofin
Partner Name Vitamin K3
Disease Info [ICD-11: 2A00] Glioblastoma multiforme Investigative
Biological Phenomena Induction-->ROS accumulation
Gene Regulation Up-regulation Expression TXNRD1 hsa7296
In Vitro Model T98G Glioblastoma Homo sapiens (Human) CVCL_0556
U-87MG ATCC Glioblastoma Homo sapiens (Human) CVCL_0022
LN-229 Glioblastoma Homo sapiens (Human) CVCL_0393
Result Our results identify TrxR1 as an attractive drug target and highlights AF as an off-patent drug candidate in GBM therapy.
Combination Pair ID: 116
Pair Name Morin, Auranofin
Partner Name Morin
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->ROS generation
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Down-regulation Expression BIRC2 hsa329
Down-regulation Expression BIRC3 hsa330
Down-regulation Expression CASP3 hsa836
Down-regulation Expression CASP8 hsa841
Down-regulation Expression CASP9 hsa842
Up-regulation Expression CYCS hsa54205
Up-regulation Cleavage PARP1 hsa142
Up-regulation Expression TNFRSF10A hsa8797
Up-regulation Expression TNFRSF10B hsa8795
Down-regulation Expression XIAP hsa331
In Vitro Model Hep 3B2.1-7 Childhood hepatocellular carcinoma Homo sapiens (Human) CVCL_0326
Result This study provides evidence that morin can enhance the anticancer activity of AF in Hep3B human hepatocellular carcinoma cells, indicating that its combination could be an alternative treatment strategy for the hepatocellular carcinoma.
03. Reference
No. Title Href
1 Menadione Potentiates Auranofin-Induced Glioblastoma Cell Death. Int J Mol Sci. 2022 Dec 11;23(24):15712. doi: 10.3390/ijms232415712. Click
2 Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells. Phytother Res. 2019 May;33(5):1384-1393. doi: 10.1002/ptr.6329. Click
It has been 46866 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP